| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,380 |
10,129 |
$2.54M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,038 |
3,456 |
$1.47M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,224 |
1,947 |
$832K |
| 80053 |
Comprehensive metabolic panel |
9,175 |
7,931 |
$762K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,056 |
4,656 |
$674K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,520 |
7,928 |
$484K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,334 |
3,882 |
$460K |
| 71046 |
Radiologic examination, chest; 2 views |
3,222 |
2,583 |
$288K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,932 |
3,709 |
$250K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,535 |
933 |
$229K |
| 80061 |
Lipid panel |
1,962 |
1,894 |
$180K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,869 |
1,593 |
$162K |
| A0999 |
Unlisted ambulance service |
146 |
131 |
$156K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,107 |
1,897 |
$144K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,178 |
914 |
$134K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,381 |
2,282 |
$130K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
148 |
121 |
$130K |
| 36415 |
Collection of venous blood by venipuncture |
9,438 |
7,309 |
$118K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,369 |
1,178 |
$104K |
| 86140 |
|
1,991 |
1,733 |
$95K |
| 99215 |
Prolong outpt/office vis |
831 |
198 |
$92K |
| 83690 |
|
1,647 |
1,417 |
$88K |
| 87077 |
|
1,050 |
880 |
$79K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,565 |
1,156 |
$73K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
600 |
419 |
$71K |
| 84484 |
|
981 |
713 |
$70K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,524 |
1,230 |
$68K |
| 81000 |
|
2,138 |
1,864 |
$66K |
| A0425 |
Ground mileage, per statute mile |
949 |
781 |
$64K |
| 87186 |
|
998 |
842 |
$59K |
| 97161 |
|
423 |
389 |
$59K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
621 |
523 |
$49K |
| 83605 |
|
859 |
748 |
$40K |
| 84703 |
|
657 |
612 |
$38K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
465 |
386 |
$36K |
| 80305 |
|
690 |
603 |
$22K |
| 81003 |
|
916 |
831 |
$22K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
159 |
155 |
$21K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
240 |
105 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
654 |
588 |
$21K |
| 87070 |
|
282 |
262 |
$19K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
75 |
71 |
$19K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
236 |
216 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
171 |
164 |
$17K |
| 84439 |
|
269 |
246 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
987 |
716 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,267 |
1,078 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
412 |
380 |
$14K |
| 85652 |
|
319 |
293 |
$13K |
| 70450 |
Computed tomography, head or brain; without contrast material |
50 |
41 |
$12K |
| 85610 |
|
334 |
267 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,228 |
1,864 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
199 |
141 |
$8K |
| 87210 |
|
235 |
155 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
516 |
491 |
$7K |
| 85027 |
|
135 |
129 |
$6K |
| 81001 |
|
162 |
157 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
109 |
107 |
$5K |
| 87081 |
|
89 |
85 |
$4K |
| 80050 |
General health panel |
23 |
23 |
$4K |
| 85730 |
|
81 |
68 |
$4K |
| 83880 |
|
56 |
38 |
$4K |
| 73610 |
|
30 |
28 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
45 |
39 |
$3K |
| 86592 |
|
139 |
123 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
49 |
49 |
$3K |
| 85379 |
|
27 |
26 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
12 |
$2K |
| 83540 |
|
75 |
68 |
$2K |
| 81025 |
|
29 |
28 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
231 |
156 |
$2K |
| 82150 |
|
25 |
13 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
77 |
61 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
13 |
13 |
$887.74 |
| 87040 |
|
24 |
12 |
$811.92 |
| 83735 |
|
13 |
12 |
$811.92 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
42 |
27 |
$802.63 |
| 83550 |
|
30 |
26 |
$792.36 |
| 82607 |
|
12 |
12 |
$714.84 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
18 |
15 |
$696.01 |
| 82570 |
|
27 |
24 |
$667.56 |
| 72100 |
|
17 |
13 |
$656.67 |
| 80320 |
|
116 |
93 |
$650.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
12 |
$449.17 |
| 86803 |
|
13 |
13 |
$443.88 |
| 82728 |
|
16 |
13 |
$285.24 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
12 |
$191.71 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
45 |
38 |
$141.71 |